Search results for: Pricing and Reimbursement

Changes in Determining Medicines Pricing in France, Germany and the UK

24 January 2013

…being discussed in pricing and reimbursement/HTA systems in France, Germany and the UK. New requirements for health technology assessment in Europe have important implications for markets and for access to…

Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing

13 October 2011

…methods and processes, and the economics of the pharmaceutical and life sciences industries. This post briefly reviews OHE’s September 2011 activities that contribute to advancing thought and stimulating innovative ideas…

Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding

26 June 2024

…Wales, and Northern Ireland. We identified and assessed the quality of current evidence on inequalities and explored ways to quantify the magnitude and variation of a selection of these inequalities….

The Dynamics of Drug Shortages

9 January 2024

…price change of other products with the same molecule, iii) market concentration, iv) demand and competition, and v) patent expiration), which can be used to determine shortages’ factors and value…

New Research: Achieving Efficient Prices for Drugs in a Global Context

7 February 2013

…in countries with universal insurance may approximate a value-based differential pricing model if willingness to pay is used appropriately in setting a cost-effectiveness threshold for pricing and reimbursement decisions. If…

Prevention in the NHS 10 Year Health Plan: Promise, limits, and the path forward

17 September 2025

…acceptability (e.g. patient attitudes and cultural factors). Vaccine uptake rhetoric vs. the reality, and the 5 A’s framework The discrepancy between high level targets, and the reality of implementation challenges,…

Latest estimates show that 20 people a day die in unrelieved pain across the UK at the end of their lives

26 November 2024

…across the UK is mounting, as populations change. People are living longer, and have increasingly complex and compounding illnesses, meaning that demand for palliative and end of life care will…

US Pharmaceutical Pricing Policies

What is the importance of US pharmaceutical pricing policies? What is the global impact of US pharmaceutical pricing policies? Why are US pharmaceutical pricing policies a hot topic? Pharmaceutical pricing…

The commercial case for investing in ALS

13 November 2025

…and accelerate unlocking disease understanding and novel target and biomarker identification and speed up drug discovery and development. These developments position ALS as a high-impact area for both scientific advancement…